Tutorials › Population Pharmacokinetics › Sampling Windows for Absorption Parameters

Rich Versus Sparse Sampling · Tutorial 3 of 599

Sampling Windows for Absorption Parameters

See how to choose oral sampling times that reveal when absorption begins and how quickly concentrations rise toward the peak.

Beginner 11 min read

What You'll Learn

  • Explain what predose concentrations can and cannot reveal about absorption after a dose.
  • Relate early postdose samples to absorption onset, lag time, and absorption rate.
  • Derive the model-based time of peak concentration and interpret its dependence on absorption.
  • Compare sampling schedules and identify when lag time and absorption rate are difficult to distinguish.
  • Recognize signs that an oral absorption model or sampling schedule is inadequate.

Why Sampling Time Matters for Absorption

After an oral dose, concentration does not usually rise instantaneously. The time before a measurable increase, the speed of the rise, and the location of the peak all depend on absorption. A concentration collected before dosing, soon after dosing, or near the expected peak therefore answers a different question. A useful design places samples where the predicted profiles for plausible absorption behaviors differ, rather than treating all samples as interchangeable.

The aim here is to understand the information supplied by three windows: predose, early postdose, and near peak. The examples use a simple oral concentration-time model to make the timing effects explicit. They illustrate design principles, not a universal schedule: suitable times depend on the drug, dose, formulation, and the parameters expected in the study population.

Model and assumptions: For one oral dose, assume a one-compartment model with first-order absorption and first-order elimination, a fixed absorption lag time \(T_{\mathrm{lag}}\), and no background concentration. For \(t\leq T_{\mathrm{lag}}\), the model predicts \(C(t)=0\). For \(t>T_{\mathrm{lag}}\), let \(\tau=t-T_{\mathrm{lag}}\). If the absorption rate \(k_a\) differs from the elimination rate \(k\), the predicted concentration is

\(C(t)=\dfrac{F D k_a}{V(k_a-k)}\left[\exp(-k\tau)-\exp(-k_a\tau)\right]\).

Here \(D\) is the oral dose, \(F\) is bioavailability, \(V\) is apparent volume, and \(k_a\) and \(k\) have units of inverse time. The model assumes a known dose and dose time, linear disposition, and a single fixed lag; it does not represent every possible absorption process.

The equation separates timing from scale. The lag shifts the profile to the right: before \(T_{\mathrm{lag}}\), the dose has not entered the modeled absorption process. The value of \(k_a\) affects how quickly the concentration rises after that point. The scale also depends on dose, bioavailability, and volume, so a concentration by itself cannot generally identify absorption timing without assumptions about the rest of the model.

What Each Sampling Window Contributes

A predose sample establishes the concentration immediately before the scheduled dose. Before a first dose, with no residual drug or other source of the measured compound, the model predicts zero. If drug from an earlier dose may remain, the predose value instead records a nonzero starting concentration. Either way, the value provides context for interpreting the postdose profile. It does not, by itself, estimate the current dose’s absorption rate or lag time: in the single-dose model, the predose sample occurs before the modeled input.

An early postdose sample can reveal whether concentrations have begun to rise and how quickly they do so. A sample taken before the true lag time may still be near baseline. That observation can help locate the onset, but one such result does not identify an exact lag: many lag times later than that sample predict the same zero concentration. Samples that bracket the likely onset are more informative. Once absorption has begun, early concentrations can help distinguish a rapid rise from a slow one, provided sampling times are accurate and the model’s other assumptions are reasonable.

A near-peak sample captures the combined effects of absorption and elimination around the time the concentration changes from rising to falling. Its timing and value can help distinguish profiles with different absorption rates. However, one sample near a predicted peak does not necessarily establish when the peak occurred. A sample before and another after the expected peak, or additional early samples, can provide evidence about the shape rather than just one concentration on that shape.

Worked Example: A Faster Rise at an Early Sampling Time

Consider two hypothetical profiles with a lag of \(0.5\) h and \(k=0.2\) h\(^{-1}\). To compare shape, use the scaled expression \(C(t)=12[\exp(-k\tau)-\exp(-k_a\tau)]\) mg/L after the lag. The scale is held fixed solely for this illustration. Compare \(k_a=0.6\) h\(^{-1}\) with \(k_a=1.2\) h\(^{-1}\), using a sample at \(t=1.5\) h.

The time since the lag is \(\tau=1.5-0.5=1.0\) h. For \(k_a=0.6\) h\(^{-1}\), \(C(1.5)=12[\exp(-0.2)-\exp(-0.6)]\) \(=12(0.818731-0.548812)\approx 3.239\) mg/L.

For \(k_a=1.2\) h\(^{-1}\), \(C(1.5)=12[\exp(-0.2)-\exp(-1.2)]\) \(=12(0.818731-0.301194)\approx 6.210\) mg/L.

At this time, the faster-absorption profile predicts a higher concentration. The example shows why an early sample can distinguish candidate absorption rates when their predicted profiles differ. It does not mean that the concentration alone proves which rate is correct: model assumptions, variability, and uncertainty in other parameters still matter.

Near-Peak Timing and Absorption Rate

The model also gives the time of the peak. For \(\tau>0\), the concentration is proportional to \(g(\tau)=\exp(-k\tau)-\exp(-k_a\tau)\). Differentiating and setting the derivative to zero identifies the time at which the profile stops rising:

$$ g'(\tau)=-k\exp(-k\tau)+k_a\exp(-k_a\tau)=0 $$

Rearranging gives \(k_a\exp(-k_a\tau)=k\exp(-k\tau)\). Taking logarithms yields \(\ln(k_a/k)=(k_a-k)\tau\). Thus, for positive unequal \(k_a\) and \(k\), the model-based peak time is:

$$ t_{\max}=T_{\mathrm{lag}}+\frac{\ln(k_a/k)}{k_a-k}. $$

This stationary point is a maximum: the concentration starts at zero after the lag, is positive for \(\tau>0\), and eventually declines toward zero under the model. The expression also shows why near-peak sampling can inform absorption. Changing \(k_a\) changes the time at which the rise gives way to decline. But \(t_{\max}\) depends on \(k\) as well as \(k_a\), so interpreting peak timing as a direct measurement of absorption requires the elimination component to be known or estimated adequately.

Worked Example: Predicting How the Peak Shifts

Suppose the hypothetical lag is \(0.5\) h and \(k=0.2\) h\(^{-1}\). Calculate the predicted peak for \(k_a=0.6\) h\(^{-1}\) and \(k_a=1.2\) h\(^{-1}\).

For \(k_a=0.6\) h\(^{-1}\), \(t_{\max}=0.5+\ln(0.6/0.2)/(0.6-0.2)\) \(=0.5+\ln(3)/0.4\) \(=0.5+2.74653\approx 3.247\) h.

For \(k_a=1.2\) h\(^{-1}\), \(t_{\max}=0.5+\ln(1.2/0.2)/(1.2-0.2)\) \(=0.5+\ln(6)/1.0\) \(=0.5+1.79176\approx 2.292\) h.

Under these assumptions, the faster absorption rate shifts the predicted peak earlier. Sampling only at one of these predicted peak times would be risky if the true rate were uncertain: a useful schedule should cover a plausible range of peak times, not just one nominal prediction.

Using Predose Measurements as Context

A predose observation is most useful when its role is interpreted correctly. A nonzero value before a dose is not evidence that the current dose has already been absorbed. It may reflect residual concentration from earlier dosing, an unexpected source of the compound, or measurement and timing issues. A model that assumes a zero starting concentration may then predict the wrong total postdose concentrations. The predose result flags this issue; it does not by itself reveal which explanation is correct.

Worked Example: Why the Predose Value Cannot Simply Be Ignored

In a hypothetical participant, the concentration just before a scheduled oral dose is \(0.30\) mg/L. A sample taken \(0.25\) h after the dose is \(0.38\) mg/L. The arithmetic difference is \(0.38-0.30=0.08\) mg/L.

That difference is not automatically the amount contributed by absorption of the new dose. The earlier concentration may change during the \(0.25\) h, and the new dose may also be entering the circulation. A model for the full profile must account for the starting concentration and the relevant dosing history rather than treating \(0.38\) mg/L as a concentration generated from zero. The predose observation therefore helps identify the starting condition that needs attention; it does not independently estimate \(k_a\) or \(T_{\mathrm{lag}}\).

Choosing and Checking a Sampling Window

A practical absorption-focused schedule usually needs more than one window. Predose measurements establish the starting context; early samples target onset and rise; near-peak samples help characterize the transition around the maximum. Which exact times to use depends on prior knowledge and the range of plausible absorption behavior. If the lag is uncertain, placing an early sample before the anticipated onset and another after it can be more revealing than placing both well after absorption has begun.

Before relying on the model-based timing argument, check the assumptions that make it meaningful. Dose and sample times should be recorded accurately, the oral dose should be taken as intended, and the measured concentrations should be compatible with the assumed one-compartment, first-order processes. In population data, individuals may differ in lag or absorption rate; one nominal schedule should therefore be judged against plausible individual profiles, not only an average profile.

Warning signs include measured concentrations that rise before the assumed lag, repeated early values inconsistent with the predicted onset, or a peak that occurs outside the sampled window. Such patterns may reflect timing errors, variable or complex absorption, a poor choice of lag model, or other model misspecification. A sparse set of points can make these explanations difficult to distinguish. Plotting observed concentrations against actual time since dose, checking predose values, and comparing predictions with observations across the early and near-peak windows are useful first checks.

An alternative is to collect dense samples across the entire concentration-time profile. This gives more direct information about its shape but increases participant burden and may be impractical in a population study. A sparse design selects a smaller number of times to target specific features, but its success depends more strongly on prior expectations and model assumptions. A sample only at the peak is not a substitute for onset samples when lag is the question; similarly, early samples alone may not show whether the rise has reached its maximum.

Common pitfall: “The first postdose sample is low, so absorption must be slow.” This conclusion is not justified by one value. The sample may have been collected before a lag ended, may reflect a low starting or scaled concentration, or may be affected by measurement variability. Interpret early values alongside the recorded dose time, predose concentration, additional early samples, and the model assumptions.

These windows provide targeted information, not guarantees of parameter identification. Lag and absorption rate can produce similar early profiles, while peak timing also depends on elimination. When the observed sampling times do not separate the candidate profiles, the data may support a range of absorption behaviors rather than a precise estimate. A well-chosen schedule makes those behaviors distinguishable as far as practical, and a careful analysis reports the remaining uncertainty.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions.

  1. In the stated single-dose model, what does a predose concentration contribute, and why does it not directly estimate the current dose’s \(k_a\)?
  2. Two samples are collected before the earliest plausible lag time. What can their near-baseline values establish, and what can they not establish?
  3. For \(T_{\mathrm{lag}}=0.25\) h, \(k=0.1\) h\(^{-1}\), and \(k_a=0.5\) h\(^{-1}\), calculate the model-based peak time.
  4. Why can a near-peak sample not, by itself, establish the absorption lag time?
  5. A participant’s predose concentration is \(0.20\) mg/L and the concentration \(0.5\) h after dosing is \(0.31\) mg/L. Is the increase of \(0.11\) mg/L necessarily the contribution from the new dose? Explain.

Solutions. (1) It records the starting concentration immediately before dosing and can flag residual drug or an unexpected baseline. In the model, absorption from the current dose has not yet begun, so the value contains no direct information about that dose’s \(k_a\). (2) They support the conclusion that measurable concentration has not risen at those times under the model, but they do not identify the exact lag or distinguish all longer lag times. (3) \(t_{\max}=0.25+\ln(0.5/0.1)/(0.5-0.1)=0.25+\ln(5)/0.4=0.25+4.02359\approx 4.274\) h. (4) A near-peak value is compatible with multiple profile shapes and lag times; one concentration does not locate when absorption began. (5) No. The predose concentration may change over the interval, while the new dose is being absorbed. The difference is arithmetic, not a separated estimate of the new dose’s contribution.

Clinical Biostats